From the Desk of the CEO

FDA has approved Azstarys (KemPharm), the first ADHD medication to combine two medications, 70% serdexmethylphenidate (SDX) and 30% immediate-release dexmethylphenidate (d-MPH), in a oncedaily capsule for treatment of ADHD in patients ages 6 years and older.

Cara Aldridge Young

More and more cases of “long COVID” are surfacing—but what does it mean, and how can clinicians respond?

Loren Bonner

Why were SARS-CoV-2 variants expected? “Ultimately, all viruses mutate all the time,” said Scott Roberts, MD, from Yale New Haven Health.

Loren Bonner

Since melatonin is naturally produced in the body and adults commonly use melatonin to fall asleep, what’s the harm in giving children melatonin to sleep?

Clarissa Chan, PharmD

The data on cannabis and its components for treatment of neurological disorders are plentiful, according to Michele Faulkner, PharmD, FASHP. “Cannabis and neurological disorders is a huge topic,” said Faulkner during an APhA2021 Virtual session on cannabis products to treat neurological disorders.

Loren Bonner